Trial Site Detail

 

Drug:	Pazopanib (Votrient)
Trial:	Pazopanib in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib (PAGIST)
Conditions:	Gastrointestinal Stromal Tumor
Trial Status:	Completed

 

Department of Oncology, St Olav Hospital       Trondheim , N-7006 Norway

 

Principal Investigator:	Heidi Knobel, MD
Contact:	Heidi Knobel, MD +47 73867830 heidi.knobel@stolav.no
Activation Status of this Site:	Closed
Notes about this Site:
Department of Oncology, St Olav Hospital Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.